InvestorsHub Logo
Followers 33
Posts 2842
Boards Moderated 2
Alias Born 10/24/2015

Re: NY1972 post# 161

Wednesday, 04/19/2023 3:25:05 PM

Wednesday, April 19, 2023 3:25:05 PM

Post# of 265
Based on the data for CTX110 (a first-gen CD19-targeted CAR-T), and discussions with regulatory agencies, the company initiated a PhII single-arm potentially registrational trial, which incorporates consolidation dosing.

Also, could have feedback from regulatory agencies for CTX130 (another first-gen CAR-T, but CD70-targeted) mid-year. I know they are hoping to move it into another registrational trial in certain R/R T-cell lymphomas.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CRSP News